Hikma Pharmaceuticals PLC
LSE:HIK

Watchlist Manager
Hikma Pharmaceuticals PLC Logo
Hikma Pharmaceuticals PLC
LSE:HIK
Watchlist
Price: 1 794 GBX -0.83% Market Closed
Market Cap: 4B GBX
Have any thoughts about
Hikma Pharmaceuticals PLC?
Write Note

Hikma Pharmaceuticals PLC
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Hikma Pharmaceuticals PLC
Long-Term Debt Peer Comparison

Comparables:
GSK
AZN
VRNA
INDV
DPH

Competitive Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Hikma Pharmaceuticals PLC
LSE:HIK
Long-Term Debt
$1.1B
CAGR 3-Years
12%
CAGR 5-Years
59%
CAGR 10-Years
15%
GlaxoSmithKline PLC
LSE:GSK
Long-Term Debt
ÂŁ13.6B
CAGR 3-Years
-13%
CAGR 5-Years
-10%
CAGR 10-Years
-1%
AstraZeneca PLC
LSE:AZN
Long-Term Debt
$28.2B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
14%
Verona Pharma PLC
NASDAQ:VRNA
Long-Term Debt
$120m
CAGR 3-Years
192%
CAGR 5-Years
172%
CAGR 10-Years
N/A
Indivior PLC
LSE:INDV
Long-Term Debt
$268m
CAGR 3-Years
-1%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
Dechra Pharmaceuticals PLC
LSE:DPH
Long-Term Debt
ÂŁ500.6m
CAGR 3-Years
13%
CAGR 5-Years
12%
CAGR 10-Years
17%

See Also

What is Hikma Pharmaceuticals PLC's Long-Term Debt?
Long-Term Debt
1.1B USD

Based on the financial report for Jun 30, 2024, Hikma Pharmaceuticals PLC's Long-Term Debt amounts to 1.1B USD.

What is Hikma Pharmaceuticals PLC's Long-Term Debt growth rate?
Long-Term Debt CAGR 10Y
15%

Over the last year, the Long-Term Debt growth was -3%. The average annual Long-Term Debt growth rates for Hikma Pharmaceuticals PLC have been 12% over the past three years , 59% over the past five years , and 15% over the past ten years .

Back to Top